97. 潰瘍性大腸炎 Ulcerative colitis Clinical trials / Disease details


臨床試験数 : 2,630 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

  
4 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2010-019970-33-GB
(EUCTR)
01/02/201113/10/2010A multi-centre, double-blind, placebo controlled, parallelgroup, proof of concept study to evaluate the efficacy,safety and tolerability of KRP203 in subjects withmoderately active refractory ulcerative colitis - Ulcerative colitis
MedDRA version: 12.1;Level: LLT;Classification code 10045365;Term: Ulcerative colitis
Product Code: KRP203A
Product Code: KRP203A
Product Code: KRP203A
Novartis Services AGNULLNot RecruitingFemale: yes
Male: yes
80Hungary;Germany;United Kingdom;Belgium;Sweden
2EUCTR2010-019970-33-BE
(EUCTR)
07/12/201020/09/2010A multi-centre, double-blind, placebo controlled, parallelgroup, proof of concept study to evaluate the efficacy,safety and tolerability of KRP203 in subjects withmoderately active refractory ulcerative colitisA multi-centre, double-blind, placebo controlled, parallelgroup, proof of concept study to evaluate the efficacy,safety and tolerability of KRP203 in subjects withmoderately active refractory ulcerative colitis Ulcerative colitis
MedDRA version: 14.0;Level: LLT;Classification code 10045365;Term: Ulcerative colitis;System Organ Class: 10017947 - Gastrointestinal disorders
Product Code: KRP203A
Product Code: KRP203A
Product Code: KRP203A
Novartis Services AGNULLNot RecruitingFemale: yes
Male: yes
72Phase 2Hungary;Belgium;Germany;United Kingdom;Sweden
3EUCTR2010-019970-33-HU
(EUCTR)
11/11/201007/09/2010A multi-centre, double-blind, placebo controlled, parallelgroup, proof of concept study to evaluate the efficacy,safety and tolerability of KRP203 in subjects withmoderately active refractory ulcerative colitis - Ulcerative colitis
MedDRA version: 12.1;Level: LLT;Classification code 10045365;Term: Ulcerative colitis
Product Name: n.a.
Product Code: KRP203A
Product Name: n.a
Product Code: KRP203A
Product Name: n.a
Product Code: KRP203A
Novartis Services AGNULLNot RecruitingFemale: yes
Male: yes
72Hungary;Germany;United Kingdom;Belgium;Sweden
4EUCTR2010-019970-33-SE
(EUCTR)
29/10/201010/09/2010A multi-centre, double-blind, placebo controlled, parallelgroup, proof of concept study to evaluate the efficacy,safety and tolerability of KRP203 in subjects withmoderately active refractory ulcerative colitisA multi-centre, double-blind, placebo controlled, parallelgroup, proof of concept study to evaluate the efficacy,safety and tolerability of KRP203 in subjects withmoderately active refractory ulcerative colitis Ulcerative colitis
MedDRA version: 12.1;Level: LLT;Classification code 10045365;Term: Ulcerative colitis
Product Name: KRP203
Product Code: KRP203A
Product Name: KRP203
Product Code: KRP203A
Product Name: KRP203
Product Code: KRP203A
Novartis Services AGNULLNot RecruitingFemale: yes
Male: yes
72Hungary;Belgium;Germany;United Kingdom;Sweden